Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rheumatic IMmune-Related Adverse Events in Patients Treated With Immune Check Point Inhibitors - a Prospective Observational Study

NCT05544292 is registered in ClinicalTrials.gov with Diakonhjemmet Hospital as lead sponsor.

NCT NCT05544292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05544292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rheumatic IMmune-Related Adverse Events in Patients Treated With Immune Check Point Inhibitors - a Prospective Observational Study
Lead sponsor
Diakonhjemmet Hospital
Phase
Observational
Overall status
Completed
Start date
March 5, 2018
Completion date
December 31, 2024
Enrollment
69 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

immune-related adverse event